Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Arianna Cafarotti"'
Autor:
Alessandro Fiocchi, Linda Monaci, Elisabetta DeAngelis, Veronica Calandrelli, Lamia Dahdah, Rocco Valluzzi, Sara Urbani, Carmen Mazzuca, Stefania Arasi, Arianna Cafarotti, Carla Riccardi, Maria Cristina Artesani, Lorenza Putignani, Valentina Pecora, Valeria Marzano, Vincenzo Fierro
Publikováno v:
Clinical and Translational Allergy, Vol 13, Iss 9, Pp n/a-n/a (2023)
Abstract Background The frequency and severity of reactions in food‐allergic consumers exposed to unintentional food allergen contamination during production is unknown. To warn allergic consumers, it has been suggested for pre‐packaged foods to
Externí odkaz:
https://doaj.org/article/cdb9357396214146a52b8c918925f96b
Autor:
Giulio Dinardo, Lamia Dahdah, Arianna Cafarotti, Stefania Arasi, Vincenzo Fierro, Valentina Pecora, Carmen Mazzuca, Sara Urbani, Maria Cristina Artesani, Carla Riccardi, Rocco Luigi Valluzzi, Cristiana Indolfi, Michele Miraglia del Giudice, Alessandro Fiocchi
Publikováno v:
Nutrients, Vol 16, Iss 5, p 628 (2024)
Background: The supply chains of food raw materials have recently been heavily influenced by geopolitical events. Products that came from, or transited through, areas currently in conflict are now preferentially supplied from alternative areas. These
Externí odkaz:
https://doaj.org/article/2f33d271f38643538c318a91c6a58bca
Autor:
Stefania Arasi, MD, PhD, MSC, Anna Lucia Piscitelli, MD, Arianna Cafarotti, MD, Beatrice Marziani, MD, Valentina Pecora, MD, Lamia Dahdah, MD, Giovanna Leone, MD, Giorgia Bracaglia, PhD, Ottavia Porzio, MD, Andrea Onetti Muda, MD, Alessandro Fiocchi, MD
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 2, Pp 100750- (2023)
Background: Children with severe food allergy may present high risk of fatal anaphylaxis and a highly impaired quality of life. Anti IgE-treatment has been shown to be a promising approach as monotherapy for severe allergy to multiple foods. However,
Externí odkaz:
https://doaj.org/article/ebef6eda74fb4dd79c453f88bb0c8b47
Autor:
Maurizio Mennini, Alessandro Giovanni Fiocchi, Arianna Cafarotti, Marilisa Montesano, Angela Mauro, Maria Pia Villa, Giovanni Di Nardo
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 10, Pp 100471- (2020)
Food protein-induced allergic proctocolitis (FPIAP) is a condition characterized by inflammatory changes in the distal colon in response to one or more foreign food proteins because of immune-mediated reactions.FPIAP prevalence estimates range widely
Externí odkaz:
https://doaj.org/article/23db4fd3694c4b47a9d7d098389e5e7d
Autor:
Antonio Mutarelli, Bruna Giavina-Bianchi, Stefania Arasi, Arianna Cafarotti, Alessandro Fiocchi
Publikováno v:
Current Opinion in Allergy & Clinical Immunology. 23:205-209
Publikováno v:
Current Opinion in Allergy & Clinical Immunology. 22:181-187
To highlight the most recent insights on cow's milk allergy (CMA), its treatment, and management.CMA is one of the most common food allergies among children. Burdened by the risk for fatal reaction, CMA may imply also a severe impairment of health-re
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical ImmunologyREFERENCES.
The 21st century has seen the propulsion of research in the field of food allergy, which has driven real changes in the clinical approach. Allergen immunotherapy has been recommended for the active management of food allergy. Data have shown promisin
Publikováno v:
Current Opinion in Allergy & Clinical Immunology. 21:455-464
Purpose of review To provide the most recent insights in the use of biologicals in the treatment of patients with anaphylaxis. Recent findings There is evidence that biologics such as omalizumab may be safe and effective in preventing anaphylactic re
Autor:
Stefania Arasi, Anna Lucia Piscitelli, Arianna Cafarotti, Beatrice Marziani, Valentina Pecora, Lamia Dahdah, Giovanna Leone, Giorgia Bracaglia, Ottavia Porzio, Andrea Onetti Muda, Alessandro Fiocchi
Background: Children with severe atopic status may present high risk of fatal or near fatal anaphylaxis and a highly impaired quality of life. Omalizumab has been shown to be a promising approach as monotherapy for severe allergy to multiple foods. H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f90f78e0e44e50dc1671de180689b4a2
https://doi.org/10.22541/au.165173769.97585396/v1
https://doi.org/10.22541/au.165173769.97585396/v1
Publikováno v:
Current opinion in allergy and clinical immunology. 21(3)
Purpose of review To familiarize the reader with the most recent insights in the use of Omalizumab (monoclonal anti-immunoglobulin E) monotherapy in the treatment of patients with severe food allergy. Recent findings The current data from early stage